Diagnosis and Treatment of Diseases of Lipid and Lipoprotein Metabolism in Adults and Children

BACKGROUND
1 Introduction to Lipids and Lipoproteins	Kenneth R. Feingold, MD
2 The Measurement of Lipids, Lipoproteins, Apolipoproteins, Fatty Acids, and Sterols, and Next Generation Sequencing for the Diagnosis and Treatment of Lipid Disorders	Ernst J Schaefer, Fumiyoshi Tsunoda, Margaret Diffenderfer, Eliana Polisecki, Ngoc Thai and Bela Asztalos
3 Utility of Advanced Lipoprotein Testing in Clinical Practice	Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
4 The Role of Lipids and Lipoproteins in Atherosclerosis	MacRae F. Linton, MD, Patricia G. Yancey, PhD, Sean S. Davies, PhD, W. Gray (Jay) Jerome, PhD, Edward F. Linton, BA, Wenliang L. Song, MD, Amanda C. Doran, PhD, MD and Kasey C. Vickers, PhD
5 Guidelines for the Management of High Blood Cholesterol	Scott M. Grundy, MD and Kenneth R. Feingold, MD
6 Risk of Fasting and Non-Fasting Hypertriglyceridemia in Coronary Vascular Disease and Pancreatitis	Deval Bhatt, M.D. and Lisa Tannock, MD
GENETIC DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM
7 Familial Hypercholesterolemia: Genes and Beyond	Bruce A. Warden PharmD, BCPS-AQ Cardiology, CLS, FNLA, FASPC, Sergio Fazio MD, PhD and Michael D. Shapiro, DO, MCR
8 Hypertriglyceridemia: Pathophysiology, Role of Genetics, Consequences, and Treatment	Alan Chait, MD and Savitha Subramanian, MD
9 Lysosomal Acid Lipase Deficiency	Don P. Wilson, MD, FNLA and Nivedita Patni, MD
10 Sitosterolemia	Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA
11 Cerebrotendinous Xanthomatosis	Nivedita Patni, MD and Don P. Wilson, MD, FNLA
12 Lipoprotein (a)	Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD
13 Monogenic Disorders Causing Hypobetalipoproteinemia	Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
14 Monogenic Disorders Altering HDL Levels	Michael D. Shapiro, DO, MCR and Kenneth R. Feingold, MD
15 Lipodystrophy Syndromes: Presentation and Treatment	Baris Akinci, Melis Sahinoz and Elif Oral
SECONDARY DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM AND SPECIAL POPULATIONS
16 Dyslipidemia in Diabetes	Kenneth R. Feingold, MD
17 Dyslipidemia in Chronic Kidney Disease	Lisa Tannock, MD
18 Lipid and Lipoprotein Metabolism in Liver Disease	David E. Cohen MD, PhD and Kathleen E. Corey MD MPH, MMSc
19 The Effect of Endocrine Disorders on Lipids and Lipoproteins	Kenneth R. Feingold, MD, Eliot A. Brinton, MD, FAHA, FNLA and Carl Grunfeld, MD, PhD
20 The Effect of Inflammation and Infection on Lipids and Lipoproteins	Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
21 Lipid Disorders In People With HIV	Sudipa Sarkar, MD, MSCI and Todd T. Brown MD, PhD
22 Lipid and Lipoprotein Levels in Patients with Covid-19 Infections	Kenneth R. Feingold, MD
23 Medication Induced Changes in Lipid and Lipoproteins	Megan Herink, Pharm.D., BCPS and Matthew K. Ito, Pharm.D., FCCP, FNLA, CLS.
24 Obesity and Dyslipidemia	Kenneth R. Feingold, MD
25 Management of Dyslipidemia in the Elderly	Elani Streja, Ph.D. and Dan Streja, MD, FRCPC, FACP, FACE,
26 Effect of Pregnancy on Lipid Metabolism and Lipoprotein Levels	Sarah B. Grimes, MD and Robert Wild, MD, MPH, PhD
TREATMENT
27 Approach to the Patient with Dyslipidemia	Kenneth R. Feingold, MD
28 The Effect of Diet on Cardiovascular Disease and Lipid and Lipoprotein Levels	Kenneth R. Feingold, MD
29 Cholesterol Lowering Drugs	Kenneth R. Feingold, MD
30 Triglyceride Lowering Drugs	Kenneth R. Feingold, MD
31 Lipoprotein Apheresis	Kenneth R. Feingold, MD and Carl Grunfeld, MD, PhD
PEDIATRIC LIPIDOLOGY
BACKGROUND
32 Is Atherosclerosis a Pediatric Disease	Don P. Wilson, MD, FNLA
33 Fetal and Neonatal Cholesterol Metabolism	Laura Woollett and James E Heubi
34 Non-Invasive Techniques In Pediatric Dyslipidemia	Damon B. Dixon, MD
35 Principles of Genetic Testing for Dyslipidemia in Children	Luke Hamilton, MS, Ariel Brautbar, MD and Don P. Wilson, MD, FNLA
36 Genetics and Dyslipidemia	Nivedita Patni, MD, Zahid Ahmad, MD and Don P. Wilson, MD, FNLA
SCREENING AND GUIDELINES
37 Guidelines for Screening, Prevention, Diagnosis, and Treatment of Dyslipidemia in Children and Adolescents	Stephen R. Daniels, MD, PhD
38 Lipid Screening in Youth	Lindsay Eilers, MD and Justin P. Zachariah MD MPH
HYPERCHOLESTEROLEMIA
39 Ethical Dilemmas in Pediatric Lipidology	G. Kevin Donovan, MD, MA and Don P. Wilson, MD, FNLA
40 Familial Hypercholesterolemia	Amy E. Levenson, MD and Sarah D. de Ferranti, MD, MPH
41 Lysosomal Acid Lipase Deficiency	Don P. Wilson, MD, FNLA and Nivedita Patni, MD
42 Sitosterolemia in the Pediatric Population	Ann Liebeskind, MD, Amy L. Peterson, MD and Don P. Wilson, MD, FNLA
43 Cerebrotendinous Xanthomatosis	Nivedita Patni, MD and Don P. Wilson, MD, FNLA
44 Lipoprotein (a) in Youth	Catherine J. McNeal, MD, PhD and Amy L. Peterson, MD
HYPERTRIGLYCERIDEMIA
45 Genetic Disorders Causing Hypertriglyceridemia in Children and Adolescents	Amy S. Shah, MD MS. and Don P. Wilson, MD, FNLA
46 Secondary Hypertriglyceridemia	Irwin Benuck, MD, PhD, Don P. Wilson, MD, FNLA and Catherine J. McNeal, MD, PhD
TREATMENT
47 Combined Dyslipidemia in Children and Adolescents	Rae-Ellen W. Kavey, MD, MPH.
48 Nutritional Management of Pediatric Dyslipidemia	Lauren A. Williams, MCN, RD and Don P. Wilson, MD, FNLA
49 Use of Lipid Lowering Medications in Youth	Melissa L Miller, PharmD, Chanin C Wright, PharmD. and Brandi Rodriguez, PharmD
50 A Clinical Approach to Aggressive Treatment of Children with Severe Hypertriglyceridemia	Alejandro De La Torre, MD, Luke Hamilton, MS and Don P. Wilson, MD, FNLA
51 Clinical Management of Dyslipidemia in Youth with Chronic Kidney Disease	Alejandro De La Torre, MD, Nivedita Patni, MD and Don P. Wilson, MD, FNLA